CAY10580
Based on 1 Customer Validation
CAY10580 is a potent and selective prostaglandin EP4 receptor agonist (Ki=35 nM).
For research use only. We do not sell to patients.
- Purity: 97.4%
- CAS No.: 64054-40-6
- Formula: C19H35NO4
- Molecular Weight:341.49
-
Storage:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
EP4 35 nM (Ki) |
EP2 3000 nM (Ki) |
EP3 2000 nM (Ki) |
EP1 >3000 nM (Ki) |
CAY10580 (10-10000 nM; 40 min) significantly increases apical membrane abundance of AQP2 in MDCK cells at 100 to 10000 nM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Six-week old male EP4+/+ mice (Treating high fat diet-challenged mice)[3]
-
Dosage:200 μg/kg body weight
-
Administration:Intraperitoneal injection; daily for remaining three weeks
-
Result:High fat diet fed mice exhibited lower total cholesterol levels compared to the vehicle group by 28.5%. Total cholesterol levels decreased from 137.4 to 98.2 mg/dl, restoring plasma cholesterol back to near-normal values.
Chemical Information
-
CAS No. 64054-40-6
-
Appearance Liquid
-
Molecular Weight 341.49
-
Formula C19H35NO4
-
Color Colorless to light yellow
-
SMILES
O=C(O)CCCCCCN1C(CCC(O)CCCCC)CCC1=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, 2 years
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Billot X, et al. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg Med Chem Lett. 2003;13(6):1129-1132. [Content Brief]
[2]. Olesen ET, et al. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A. 2011;108(31):12949-12954. [Content Brief]
[3]. Ying F, et al. EP4 emerges as a novel regulator of bile acid synthesis and its activation protects against hypercholesterolemia. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(9):1029-1040. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CAY10580 Related Classifications
HY-135259 Related Classifications
Powered by Bioz